Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Coagulation factor XI | ||
Ligand | BDBM304210 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Factor XIa Assay | ||
IC50 | 1.80±n/a nM | ||
Citation | Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS Factor XIa inhibitors US Patent US10143681 Publication Date 12/4/2018 | ||
More Info.: | Get all data from this article, Assay Method | ||
Coagulation factor XI | |||
Name: | Coagulation factor XI | ||
Synonyms: | Coagulation factor XIa | Coagulation factor XIa heavy chain | Coagulation factor XIa light chain | F11 | FA11_HUMAN | FXI | Factor XIa | Factor XIa (fXIa) | PTA | Plasma thromboplastin antecedent | ||
Type: | Enzyme | ||
Mol. Mass.: | 70130.58 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P03951 | ||
Residue: | 625 | ||
Sequence: |
| ||
BDBM304210 | |||
n/a | |||
Name | BDBM304210 | ||
Synonyms: | 2-(1-((4- carboxyphenyl)amino)-3-(3- fluorocyclobutyl)-1- oxopropan-2-yl)-5-(3- chloro-6-(difluoromethoxy)- 2-fluorophenyl)pyridine 1- oxide | BDBM304211 | US10143681, Example 101 | ||
Type | Small organic molecule | ||
Emp. Form. | C26H21ClF4N2O5 | ||
Mol. Mass. | 552.902 | ||
SMILES | OC(=O)c1ccc(NC(=O)C(CC2CC(F)C2)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2OC(F)F)cc1 |$;;;;;;;HN;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;$,(8,-3.24,;8,-1.7,;9.34,-.93,;6.67,-.93,;5.33,-1.7,;4,-.93,;4,.61,;2.67,1.38,;1.33,.61,;1.33,-.93,;,1.38,;,2.92,;-1.33,3.69,;-2.82,3.29,;-3.22,4.78,;-4.55,5.55,;-1.73,5.18,;-1.33,.61,;-2.67,1.38,;-4,.61,;-4,-.93,;-2.67,-1.7,;-1.33,-.93,;,-1.7,;-5.33,-1.7,;-5.33,-3.24,;-4,-4.01,;-6.67,-4.01,;-6.67,-5.55,;-8,-3.24,;-8,-1.7,;-6.67,-.93,;-6.67,.61,;-8,1.38,;-8,2.92,;-9.34,.61,;5.33,1.38,;6.67,.61,)| | ||
Structure |